Scholars Central

Conference abstract

Model based drug development: Promises towards success

Authors: A. T. Sangamwar

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T he innovative and reproducible approach of model based drug development (MBDD) to drug discovery and development has promising output in placing the New Chemical Entities (NCEs?) into the market place. It has reduced the attrition of the large number of molecules, which are in clinical trials. The bottle necks of poor pharmacokinetics and efficacy and safety of the drug molecules can be addressed with MBDD with better options. This paradigm shift of empirical drug development to MBDD is explored here with some case studies. The requirements to implement this approach is also discussed PDF HTML

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “A. T. Sangamwar”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels